Brief: PledPharma Q1 Result At Loss SEK 15.8 Mln
April 24 (Reuters) - PledPharma AB (publ) PLED.ST :
* Q1 QUARTERLY RESULT MSEK -15,8 (-12,3)
* Q1 CASH POSITION MSEK 294,3 (382,0)
Source text for Eikon: ID:nGNE3J28dh
Further company coverage: PLED.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1